Frontlight ResearchEarly access
Trial site
New York Presbyterian/Weill Cornell
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)2 trials
- Hepatitis B2 trials
- Hepatitis C2 trials
- Liver cirrhosis2 trials
- Acute myeloid leukaemia1 trial
- Ovarian cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Incyte Corporation1 trial
- Janssen Research & Development, LLC1 trial
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1 trial
- Northwestern University1 trial
- Weill Medical College of Cornell University1 trial
Running trials
Recruiting
Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Hepatitis B1 recruiting
- Hepatitis C1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026